Advanced search
Publication Cover
Gynecological Endocrinology Volume 37, 2021 - Issue 4
Submit an article Journal homepage
161
Views
0
CrossRef citations to date
0
Altmetric
OVARIAN TRANSPLANTATION

Anti-Müllerian Hormone (AMH) regulates BRCA1 and BRCA2 gene expression after ovarian cortex transplantation

Irene Peregrin-Alvareza Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, TN, USAView further author information
,
Nicole M. Fletcherb The C. S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI, USAView further author information
,
Ghassan M. Saedb The C. S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI, USAView further author information
,
Robert A. Romana Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, TN, USAView further author information
&
Laura Dettia Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, TN, USA;c Women’s Health Institute, Department of Ob-Gyn Subspecialty Women’s Care, Cleveland Clinic, Women’s Health Institute, Cleveland, OH, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6868-7185View further author information
ORCID Icon
Pages 349-352 | Received 03 May 2020, Accepted 21 Sep 2020, Published online: 21 Oct 2020

References

  • Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002;108(2):171–182.
  • Pal T, Keefe D, Sun P, et al. Fertility in women with BRCA mutations: a case-control study. Fertil Steril. 2010;93(6):1805–1808.
  • Titus S, Li F, Stobezki R, et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013;5(172):172ra21.
  • Wang ET, Pisarska MD, Bresee C, et al. BRCA1 germline mutations may be associated with reduced ovarian reserve. Fertil Steril. 2014;102(6):1723–1728.
  • Phillips KA, Collins IM, Milne RL, et al. Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab). Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Hum Reprod. 2016;31(5):1126–1132.
  • Giordano S, Garrett-Mayer E, Mittal N, et al. Association of BRCA1 mutations with impaired ovarian reserve: connection between infertility and breast/ovarian cancer risk. J Adolesc Young Adult Oncol. 2016;5(4):337–343.
  • Oktay K, Kim JY, Barad D, et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28(2):240–244.
  • Oktay K, Turan V, Titus S, et al. BRCA mutations, DNA repair and ovarian aging. Biol Reprod. 2015;93(3):1–10.
  • Detti L, Christiansen ME, Francillon L, et al. Serum Anti-Müllerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses. Syst Biol Reprod Med. 2019;65(2):147–154.
  • Kelsey TW, Anderson RA, Wright P, et al. Data-driven assessment of the human ovarian reserve. Mol Hum Reprod. 2012;18(2):79–87.
  • Freeman EW, Sammel MD, Lin H, et al. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab. 2012;97(5):1673–1680.
  • Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij IA, et al. Anti-Müllerian hormone predicts menopause: a long-term follow up study in normo-ovulatory women. J Clin Endocrinol Metab. 2011;96(8):2532–2539.
  • Nelson SM, Yates RW, Fleming R. Serum anti-mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles—implications for individualization of therapy. Hum Reprod. 2007;22(9):2414–2421.
  • Celik E, Bastu E, Dural O, et al. Relevance of anti-mullerian hormone on in vitro fertilization outcome. Clin Exp Obstet Gynecol. 2013;40(1):66–69.
  • Detti L, Fletcher NM, Saed GM, et al. Anti-Müllerian Hormone (AMH) may stall ovarian cortex function through modulation of hormone receptors other than the AMH receptor. Reprod Sci. 2018;25(8):1218–1223.
  • Detti L, Fletcher NM, Uhlmann RA, et al. Anti-Müllerian hormone (AMH) regulates stemness-promoting factors in fresh and previously vitrified-warmed ovarian cortex. Minerva Ginecol. 2019;71(3):249–253.
  • Detti L, Fletcher NM, Saed GM, et al. Xenotransplantation of pre-pubertal ovarian cortex and prevention of follicle depletion with anti-Müllerian hormone (AMH). J Assist Reprod Genet. 2018;35(10):1831–1841.
  • Van Eyck AS, Bouzin C, Feron O, et al. Both host and graft vessels contribute to revascularization of xenografted human ovarian tissue in a murine model. Fertil Steril. 2010;93(5):1676–1685.
  • Kano M, Sosulski AE, Zhang L, et al. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Natl Acad Sci USA. 2017;114(9):E1688–E1697.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.